Last reviewed · How we verify
Placebo matched to doxycycline
This is a placebo control arm matched to doxycycline and does not exert any therapeutic effect.
At a glance
| Generic name | Placebo matched to doxycycline |
|---|---|
| Sponsor | Hamilton Health Sciences Corporation |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to establish the efficacy of the active comparator (doxycycline). It contains no active pharmaceutical ingredient and serves to blind trial participants and investigators to treatment assignment.
Approved indications
Common side effects
Key clinical trials
- FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis (PHASE4)
- Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline (PHASE2)
- A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) (PHASE3)
- A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (PHASE3)
- A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) (PHASE4)
- A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India (PHASE3)
- A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (PHASE3)
- Cholera Anti-Secretory Treatment Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo matched to doxycycline CI brief — competitive landscape report
- Placebo matched to doxycycline updates RSS · CI watch RSS
- Hamilton Health Sciences Corporation portfolio CI